- GeoVax Labs (NASDAQ:GOVX +14.2%) says that that the U.S. Department of Defense has awarded the Company a $2.44M cooperative agreement in support of its novel Lassa Fever vaccine development program.
- In addition to the grant funds provided directly to GeoVax, DoD will also fund testing of the GeoVax vaccine by U.S. Army scientists under a separate subaward.
- Press Release
GeoVax awarded $2.4M from U.S. Department of Defense
Recommended For You
More Trending News
About GOVX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
GOVX | - | - |
GeoVax Labs, Inc. |